Smilegate Investment
VC Fund
Seongnam, South Korea
Smilegate Investment is a VC fund in Seongnam focused on Software and Artificial Intelligence. Smilegate Investment, founded in 1999 originally as MVP Capital, is a venture capital and private equity firm that grows remarkably alongside invested companies. Since initial venture capital funding in 2000, the firm has since organized and managed more than 30 venture capital and private equity funds and has invested in more than 200 companieswith promising growth potential.
- Total investments:
- 279
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Smilegate Investment invests in
Stages Smilegate Investment invests in
Countries Smilegate Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $694k–$6.6M
- Series A
- $1.2M–$15M
- Series B
- $3.4M–$47M
Investment Focus
Industry
- Software 36 (13%)
- Artificial Intelligence 32 (11%)
- Health Care 27 (10%)
- Information Technology 27 (10%)
- Biotechnology 20 (7%)
Stage
- Series B 56 (20%)
- Series A 55 (20%)
- Seed 54 (19%)
- Series C 18 (6%)
- Funding Round 16 (6%)
Country
- South Korea 142 (51%)
- United States 27 (10%)
- Vietnam 4 (1%)
- India 2 (1%)
- China 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hoon-gon Nam
Senior Manager
|
Senior Manager | Total investments: 5 | Find email | |
Insoo Paik
Principal
|
Principal | Total investments: 13 | Find email | |
Inwoo Kang
General Manager
|
General Manager | Total investments: 1 | Find email | |
Jong Hyuk Park
Executive Vice President
|
Executive Vice President | Total investments: 0 | Find email | |
Kimoon Nam
CEO
|
CEO | Total investments: 2 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prazer Therapeutics
|
Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology. | $33.9M / Venture - Series Unknown / Jul 23, 2026 | |
Hookable
|
Hookable is an AI-based e-commerce detail page automatic generation solution. | Seed / Jul 16, 2026 | |
Neardoc
|
Neardoc operates on a business-to-business subscription model providing an ambient artificial intelligence scribe solution for healthcare facilities. The platform leverages a proprietary medical reasoning engine to automatically generate structured clinical SOAP notes by analyzing doctor-patient conversations in real time. Its core valueproposition centers on eliminating administrative overhead, reducing charting time for medical professionals, and increasing patient throughput. | Seed / Jul 06, 2026 | |
fapis
|
Fapis is a repair firm for mobile, handbags, shoes, and cloth services. | Series A / Jul 02, 2026 | |
WIRobotics
|
WIRobotics is a Wearable robot that lessen physical demands on your body to safely allow active motion. | $63.5M / Series B / May 15, 2026 | |
AstralQ
|
AstralQ builds an AI-powered end-to-end materials development cloud lab. It develops Machine-learned Hamiltonian models for large-scale electronic structure computations and Machine-learned Force Field models trained on proprietary DFT datasets. The company operates an automated inorganic synthesis lab to validate AI predictions through physicalexperiments. | Seed / May 07, 2026 | |
GGWP
|
GGWP provides a gaming tool to help reduce toxic and disruptive in the game. | $15M / Series A / Apr 30, 2026 | |
Aim Intelligence
|
Aim Intelligence has developed 'AIM Red', a generative AI solution for automatic vulnerability detection and security diagnosis. AIM Red, a security performance evaluation solution for generative AI, automates attack prompt creation for enterprises' red teams. | $6.7M / Series A / Apr 10, 2026 | |
Anabatic Semiconductor
|
Anabatic Manufacturing of electronic components, computers, video, audio, and communication equipment | $10M / Series B / Mar 25, 2026 | |
RLWRLD
|
RLWRLD specializes in "Physical AI" by creating robotics foundation models (RFMs) designed to enable robots to function autonomously in real-world environments. | $26M / Seed / Feb 25, 2026 | |
| See all 279 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Smilegate Investment invest in?
Smilegate Investment invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series B and Series A stage. Most of the 279 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Smilegate Investment's check size?
Smilegate Investment typically joins rounds of $694k–$6.6M at Seed, $1.2M–$15M at Series A and $3.4M–$47M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Smilegate Investment participates in.
How do I contact Smilegate Investment?
Public channels for Smilegate Investment include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Smilegate Investment?
The team at Smilegate Investment includes Hoon-gon Nam (Senior Manager), Insoo Paik (Principal) and Inwoo Kang (General Manager), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
